Bliss GVS Pharma Falls 4.44%: 4 Key Technical and Fundamental Factors This Week
2026-11-21 16:02:21Key Events This Week 16 Nov: Upgrade to Buy rating and bullish technical momentum shift 17 Nov: Mild price decline amid Sensex gains 18 Nov: Technical momentum moderates to mildly bullish 19 Nov: Mixed technical signals with bullish outlook 20 Nov: Sharp price drop on heavy volume closes week lower Week OpenRs.673.00 <div clas...
Read More
Bliss GVS Pharma Ltd Technical Momentum Shifts Signal Bullish Outlook
2026-11-19 08:03:28Bliss GVS Pharma Ltd has exhibited a notable shift in its technical momentum, with key indicators signalling an increasingly bullish trend. The stock’s recent upgrade from a Hold to a Buy rating, alongside improved moving averages and positive monthly MACD readings, suggests growing investor confidence in this small-cap pharmaceutical player amid a volatile market backdrop.
Read More
Bliss GVS Pharma Ltd Technical Momentum Shifts Amid Strong Long-Term Returns
2026-11-18 08:03:15Bliss GVS Pharma Ltd has experienced a nuanced shift in its technical momentum, moving from a bullish to a mildly bullish stance as of mid-November 2026. This subtle change is reflected across key technical indicators including MACD, RSI, moving averages, and Bollinger Bands, suggesting a cautious but positive outlook for the small-cap pharmaceutical player amid a volatile market backdrop.
Read More
Bliss GVS Pharma Upgraded to Buy on Strong Financials and Bullish Technicals
2026-11-16 08:17:12Bliss GVS Pharma Ltd has been upgraded from a Hold to a Buy rating following a comprehensive reassessment of its quality, valuation, financial trends, and technical outlook. The upgrade reflects the company’s robust quarterly results, improved technical indicators, and sustained market-beating returns, despite some valuation concerns and risks related to promoter share pledging.
Read More
Bliss GVS Pharma Ltd Sees Bullish Momentum Shift Amid Strong Technical Signals
2026-11-16 08:02:33Bliss GVS Pharma Ltd has demonstrated a significant shift in price momentum, supported by a range of technical indicators signalling a bullish trend. The pharmaceutical small-cap stock has outperformed the broader market with a 4.97% gain on 16 Nov 2026, reflecting renewed investor confidence and a positive outlook for the sector.
Read More
Bliss GVS Pharma Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-11-09 11:00:11At Rs 655.4, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bliss GVS Pharma Ltd locked at its upper circuit of 5% on 09 Nov 2026, with buyers queuing and no sellers willing to part with shares.
Read More
Bliss GVS Pharma Ltd is Rated Hold by MarketsMOJO
2026-11-05 10:11:34Bliss GVS Pharma Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 13 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 05 November 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Bliss GVS Pharma Ltd Locks at Upper Circuit With 3.22% Gain — Buyers Queue, Sellers Absent
2026-11-05 10:01:17At Rs 639.5, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Bliss GVS Pharma Ltd locked at its upper circuit of 3.22% on 5 Nov 2026, with buyers queuing and no sellers willing to part with shares.
Read MoreBliss GVS Pharma Gains 3.17%: 2 Key Events Shaping the Week
2026-10-31 16:02:09Key Events This Week 26 Oct: Stock opens at Rs.617.15, down 1.81% despite Sensex rally 27 Oct: Strong rebound with 4.28% gain to Rs.643.55 29 Oct: Hits upper circuit at Rs.680.90 (+4.86%) amid robust buying 30 Oct: Hits lower circuit at Rs.646.90 (-5.00%) amid heavy selling Week Close: Rs.648.40, net +3.17% vs Sensex +2.12% Week OpenRs.628.50 ...
Read MoreShareholder Meeting / Postal Ballot-Scrutinizer"s Report
17-Nov-2026 | Source : BSEPlease find enclosed herewith the disclosure of voting results of the Postal Ballot Notice dated September 28 2026 through the remote e-voting process along with the Scrutinizers Report/
Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot
17-Nov-2026 | Source : BSEPlease find enclosed herewith the Disclosure of Voting Result of the Postal Ballot Notice dated September 28 2026 through the remote e-voting process alongwith the Scrutinizers Report
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)
06-Nov-2026 | Source : BSEPlease find enclosed herewith the Intimation under Regulation 30 of the SEBI Listing Regulations.
Corporate Actions
No Upcoming Board Meetings
Bliss GVS Pharma Ltd has declared 100% dividend, ex-date: 08 Jul 26
Bliss GVS Pharma Ltd has announced 1:10 stock split, ex-date: 11 Mar 08
Bliss GVS Pharma Ltd has announced 3:5 bonus issue, ex-date: 26 Sep 08
No Rights history available